Post-bone marrow transplant thrombotic microangiopathy
Haematopoietic cell transplants in Latin America
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
MRD-driven treatment paradigm for newly diagnosed transplant eligible multiple myeloma patients
The devil is in the T cells: relapsing after haploidentical hematopoietic cell transplantation
Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect?
Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group
Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors
Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the ‘Head Start’ trials, 1991-2009
Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index
Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
Personalized home-based interval exercise training may improve cardiorespiratory fitness in cancer patients preparing to undergo hematopoietic cell transplantation
Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients
Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults
Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation
Efficacy of narrow band UVB in the treatment of cutaneous GvHD: an Indian experience
Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT
Gonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantation
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation
Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients
Regionalization of stem cell transplant procedures into teaching hospitals in United States: are we ready?
An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies
A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary
Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned
Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study
Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients